hit counter
Amphastar Pharmaceuticals, Inc. (AMPH) Stock News Sentiment & Price - Sentifly
AMPH - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Amphastar Pharmaceuticals, Inc. (AMPH)

USA
Drug Manufacturers - Other
NASDAQ
AMPH Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AMPH Latest news
Accesswire
Neutral
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
2021-11-11 16:05

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 11, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P.

Seeking Alpha
Neutral
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2021 Results - Earnings Call Transcript
2021-11-08 20:56

Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Beat Estimates
2021-11-08 19:54

Amphastar (AMPH) delivered earnings and revenue surprises of 109.09% and 8.93%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Benzinga
Neutral
Amphastar Pharmaceuticals: Q3 Earnings Insights
2021-11-08 17:46

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

Zacks Investment Research
Neutral
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: What to Know Ahead of Q3 Release
2021-10-29 16:48

Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Accesswire
Neutral
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021
2021-10-28 16:05

RANCHO CUCAMONGA, CA / ACCESSWIRE / October 28, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2021 ended September 30, 2021, after the market closes on Monday, November 8, 2021, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

Accesswire
Neutral
Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021-09-02 16:05

RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Executive V.P.

Zacks Investment Research
Positive
3 Generic Drug Stocks to Watch Amid Pandemic & Pricing Pressure
2021-08-17 12:10

The impact of the coronavirus pandemic on the Zacks Medical-Generic Drugs industry is expected to recede in the second half of 2021. Moreover, stable pricing and improving demand in some countries in 2021 may bode well for RDY, BHC and AMPH.

Seeking Alpha
Neutral
Amphastar Pharmaceuticals, Inc. (AMPH) on Q2 2021 Results - Earnings Call Transcript
2021-08-09 23:52

Amphastar Pharmaceuticals, Inc. (AMPH) on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Neutral
Amphastar Pharmaceuticals (AMPH) Meets Q2 Earnings Estimates
2021-08-09 19:59

Amphastar (AMPH) delivered earnings and revenue surprises of 0.00% and 0.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Loading more news...